Buproprion or Zyban
Burpoprion (drug name) or Zyban (brand name) is a prescription-only drug taken as a course of tablets lasting around 8 weeks. It is safe for most health adults but there are more side effects than with other pharmacological aids.
It is recommended that all quit smoking attempts with or without pharmacological aid should be made in combination with motivational support techniques as this increases the chance of success.
Latest Archived Items - access the rest of the archive here
NICE Technology Appraisal Guidance - Bupropion and NRT (External Web Page)
Guidance by National Institute of Clinical Excellence (NICE) Technology Appraisal Guidance No. 38 Smoking cessation - bupropion and nicotine replacement therapy. Technology Appraisal Guidance TGA39 Smoking cessation - bupropion and nicotine replacement therapy.
Issue Date: March 2002 Review Date: March 2005
Guidance on NRT and Bupropion (Zyban) (External Web Page)
2002/02 National Institute of Clinical Excellence (NICE) recommends use of smoking cessation therapies. NICE gives unequivocal endorsement to the use of Nicotine replacement therapies or Buproprion (Zyban) for smokers who wish to quit.
ASH summary position on NRT and Zyban for smoking cessation
Summary of views on smoking cessation drugs provided for the NICE Appraisal Committee's. Arguments are given from the smoker's perspective for mainstreaming these products in the NHS.
